// App-Quantinova.ai

THU0604 : UNDIAGNOSED RHEUMATIC DISEASE IN NEWLY PRESENTING MGUS PATIENT

Researchers

Presenter

  • Q. Zhou

Principal Investigators

  • K. Wang

  • L. Rahman

  • A. Watad

  • S. Savic

  • E. Roman

  • D. Mcgonagle

Medical Centers

  • National Institute for Health Research, Leeds Biomedical Research Centre and Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), Leeds, United Kingdom

  • Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, Department of Nephrology, Chengdu, China

  • University of Sheffield School of Medicine, Sheffield, United Kingdom

  • St James’s University Hospital, Department of Clinical Immunology and Allergy, Leeds, United Kingdom

  • University of York, Epidemiology & Cancer Statistics Group (ECSG), Department of Health Sciences, York, United Kingdom

Locations

  • United Kingdom

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Solid malignancies

  • Monoclonal gammopathy

Biomarkers

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Janssen Research & Development

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved